H.R. 9559 · 117th Congress · House

Innovative Technologies Impacted by COVID–19 Act

Active· Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determ…
Introduced
Dec 14, 22
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending

Executive Summary

Innovative Technologies Impacted by COVID-19 Act

This bill extends for one year certain Medicare pass-through payment adjustments for new drugs or biologics that would otherwise expire on December 31, 2022.

Action Timeline

4
  1. DEC 14, 2022IntroReferral

    Introduced in House

  2. DEC 14, 2022IntroReferral

    Introduced in House

  3. DEC 14, 2022IntroReferral

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  4. DEC 14, 2022IntroReferral

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Committees

2

Ways and Means Committee

hswm00

Referred: Dec 14, 2022

Active

Energy and Commerce Committee

hsif00

Referred: Dec 14, 2022

Active